balanced salt solution hbss medium (Thermo Fisher)
99
Structured Review
Thermo Fisher
balanced salt solution hbss medium
Balanced Salt Solution Hbss Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+salt+solution+hbss+medium/Hanks'+Balanced+Salt+Solution/pm40295486-518-45-50
Average 99 stars, based on 1 article reviews
Balanced Salt Solution Hbss Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/balanced+salt+solution+hbss+medium/Hanks'+Balanced+Salt+Solution/pm40295486-518-45-50
Average 99 stars, based on 1 article reviews
balanced salt solution hbss medium - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Formulation:Article Title: An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens Article Snippet: .. Cells were washed and treated with the respective chemical (MPN at 10 and 100 μM; NM102 at 10 and 300 μM; NM102 formulation at 1.29 and 5.16 mM) or their respective control (10% DMSO or empty formulation) in a total volume of 100 μL in Hanks’ Control:Article Title: An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens Article Snippet: .. Cells were washed and treated with the respective chemical (MPN at 10 and 100 μM; NM102 at 10 and 300 μM; NM102 formulation at 1.29 and 5.16 mM) or their respective control (10% DMSO or empty formulation) in a total volume of 100 μL in Hanks’ Article Title: An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens. Article Snippet: .. Cells were washed and treated with the respective chemical (MPN at 10 and 100 μM; NM102 at 10 and 300 μM; NM102 nanoformulation at 1.29 and 5.16mM) or their respective control (10% DMSO or empty nanoformulation) in a total volume of 100 μL in Hanks’ Article Title: An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens Article Snippet: .. Cells were washed and treated with the respective chemical (MPN at 10 and 100 μM; NM102 at 10 and 300 μM; NM102 nanoformulation at 1.29 and 5.16 mM) or their respective control (10% DMSO or empty nanoformulation) in a total volume of 100 μL in Hanks’ Cell Isolation:Article Title: Clonally expanded CD8 T cells characterize Amyotrophic Lateral Sclerosis 4 Article Snippet: .. Cell isolation for splicing analysis After intracardiac perfusion, spinal cords from 10–12 month old KI and WT mice were dissociated in Hank’s Incubation:Article Title: Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy Article Snippet: On Day 30 of differentiation, cells were replated, as described earlier, onto PO/FN/LN-coated dishes or Labtek slides (NuncTM) and γ-secretase inhibitor DAPT (10 μM, Tocris) was added until collection at Day 65–70. .. Differentiated 70-day-old mDA neurons, seeded on Labtek slides (NuncTM), were incubated with Hanks’ |